EP Patent

EP1386672A1 — Fluid droplet production apparatus

Assigned to PARI Pharma GmbH · Expires 2004-02-04 · 22y expired

What this patent protects

A fluid dispersion device comprises a substrate (3) having an outer section (25) and an inner section (26), said inner section (26) of the substrate (3) having an aperture (11), a dispersion element (10) positioned at said aperture (11) of said substrate (3), and an actuator (4) …

USPTO Abstract

A fluid dispersion device comprises a substrate (3) having an outer section (25) and an inner section (26), said inner section (26) of the substrate (3) having an aperture (11), a dispersion element (10) positioned at said aperture (11) of said substrate (3), and an actuator (4) arranged to coaxially surround said aperture (11) of said substrate (3), wherein the outer edge of said inner section (26) of said substrate (3) is coupled to said outer section (25) of said substrate by a plurality of resilient members (81, 82, 83).

Drugs covered by this patent

Patent Metadata

Patent number
EP1386672A1
Jurisdiction
EP
Classification
—
Expires
2004-02-04
Drug substance claim
No
Drug product claim
No
Assignee
PARI Pharma GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.